Literature DB >> 14633931

Performance of bilirubin determinations in US laboratories--revisited.

Stanley F Lo1, Basil T Doumas, Edward R Ashwood.   

Abstract

BACKGROUND: The diagnosis and management of hyperbilirubinemia in the newborn requires accurate and precise bilirubin determinations. We evaluated the current status of bilirubin measurements in US laboratories by examining data submitted by laboratories participating in the College of American Pathologists (CAP) Neonatal Bilirubin (NB) and Chemistry (C) Surveys.
METHODS: We analyzed specimens from the CAP NB and C Surveys by the reference method for total bilirubin in three laboratories. The reference method bilirubin values were compared with bilirubin values reported by Survey participants.
RESULTS: The imprecision (CV) for all instruments combined (CAP-All Instruments) ranged from 4.7% to 5.6% at the bilirubin concentrations tested. The CVs of the four most commonly used instruments were smaller, ranging from 1.9% to 4.5%. Differences between bilirubin values by the reference method and mean values from the four most common instruments ranged from -21.6% to 10.9%. When the same specimens from the NB Surveys were used in the C Surveys, the Vitros values were strikingly different from those of the NB Surveys. The use of different methods in the NB and C Surveys coupled with the presence of a nonhuman protein base and ditaurobilirubin (DTB) in the Survey specimens accounted for the discrepant results.
CONCLUSIONS: The evaluation of accuracy is impossible from the CAP Surveys because the specimens consist of bovine serum containing a mixture of unconjugated bilirubin and DTB. For the evaluation of accuracy, we recommend that Survey specimens consist of human serum enriched with unconjugated bilirubin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633931     DOI: 10.1373/clinchem.2003.019216

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches.

Authors:  R Keren; V K Bhutani; X Luan; S Nihtianova; A Cnaan; J S Schwartz
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

2.  Newborns bilirubin concentration determined by different methods in relation to hematocrit and albumin level.

Authors:  Joanna Berska; Jolanta Bugajska; Krystyna Sztefko
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

3.  Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.

Authors:  V K Bhutani; R Poland; L D Meloy; T Hegyi; A A Fanaroff; M J Maisels
Journal:  J Perinatol       Date:  2016-03-03       Impact factor: 2.521

4.  Measurements of neonatal bilirubin and albumin concentrations: a need for improvement and quality control.

Authors:  Deirdre E van Imhoff; Peter H Dijk; Cas W Weykamp; Christa M Cobbaert; Christian V Hulzebos
Journal:  Eur J Pediatr       Date:  2011-01-07       Impact factor: 3.183

5.  Establishment of age- and sex-specific reference intervals for serum liver function tests in pediatric population aged 1-<18 years: A prospective study.

Authors:  Xuetong Zhu; Kaijin Wang; Qi Zhou; Jiancheng Xu
Journal:  J Clin Lab Anal       Date:  2021-01-22       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.